Shares of Fusion Antibodies plc (LON:FAB – Get Free Report) traded down 6.5% during trading on Wednesday . The company traded as low as GBX 11.22 and last traded at GBX 11.22. 221,346 shares changed hands during trading, a decline of 51% from the average daily volume of 455,159 shares. The stock had previously closed at GBX 12.
Fusion Antibodies Stock Down 6.5%
The company has a debt-to-equity ratio of 92.42, a current ratio of 1.80 and a quick ratio of 2.36. The firm has a market capitalization of £14.03 million, a P/E ratio of -7.48 and a beta of 1.22. The company’s 50-day simple moving average is GBX 13.10 and its two-hundred day simple moving average is GBX 13.68.
About Fusion Antibodies
The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation. These services include antigen expression, antibody production, purification and sequencing, antibody humanisation using Fusion’s proprietary CDRx TM platform and the production of antibody generating stable cell lines to provide material for use in clinical trials.
Featured Articles
- Five stocks we like better than Fusion Antibodies
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Fusion Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
